Healthcare provider profile · identity verified

Levonne Marie Mitchell-Samon, M.D.

Internal Medicine · WINSTON SALEM, NC · NPI 1770542813

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	359	121
Gabapentin	Gabapentin	357	117
Albuterol Sulfate Hfa	Albuterol Sulfate	349	108
Amlodipine Besylate	Amlodipine Besylate	310	101
Losartan Potassium	Losartan Potassium	201	60
Lisinopril	Lisinopril	189	60
Hydrochlorothiazide	Hydrochlorothiazide	159	57
Rosuvastatin Calcium	Rosuvastatin Calcium	146	50
Fluticasone Propionate	Fluticasone Propionate	144	64
Potassium Chloride	Potassium Chloride	144	39
Levothyroxine Sodium	Levothyroxine Sodium	138	35
Furosemide	Furosemide	129	44
Carvedilol	Carvedilol	114	29
Famotidine	Famotidine	112	41
Omeprazole	Omeprazole	108	42
Hydroxyzine Hcl	Hydroxyzine Hcl	98	32
Metformin Hcl	Metformin Hcl	96	36
Diclofenac Sodium	Diclofenac Sodium	94	40
Duloxetine Hcl	Duloxetine Hcl	93	25
Prednisone	Prednisone	88	66
Meloxicam	Meloxicam	81	32
Pantoprazole Sodium	Pantoprazole Sodium	79	25
Metoprolol Succinate	Metoprolol Succinate	74	28
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	69	26
Tizanidine Hcl	Tizanidine Hcl	69	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	18
Trazodone Hcl	Trazodone Hcl	62	20
Eliquis	Apixaban	61	11
Triamcinolone Acetonide	Triamcinolone Acetonide	61	26
Metformin Hcl Er	Metformin Hcl	58	17
Montelukast Sodium	Montelukast Sodium	57	22
Nystatin	Nystatin	57	27
Quetiapine Fumarate	Quetiapine Fumarate	57	16
Ozempic	Semaglutide	56	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	16
Allopurinol	Allopurinol	51	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	18
Telmisartan	Telmisartan	48	12
Hydralazine Hcl	Hydralazine Hcl	47	13
Warfarin Sodium	Warfarin Sodium	47	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	46	24
Pregabalin	Pregabalin	46	14
Glipizide	Glipizide	45	15
Tamsulosin Hcl	Tamsulosin Hcl	45	17
Meclizine Hcl	Meclizine Hcl	44	18
Pravastatin Sodium	Pravastatin Sodium	44	16
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	43	suppressed
Azithromycin	Azithromycin	42	29
Jardiance	Empagliflozin	40	suppressed
Valacyclovir	Valacyclovir Hcl	37	11
Mirtazapine	Mirtazapine	35	16
Fluconazole	Fluconazole	34	23
Bumetanide	Bumetanide	33	13
Bupropion Xl	Bupropion Hcl	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Ezetimibe	Ezetimibe	30	11
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	13
Simvastatin	Simvastatin	29	11
Doxycycline Monohydrate	Doxycycline Monohydrate	28	24
Alendronate Sodium	Alendronate Sodium	27	suppressed
Sertraline Hcl	Sertraline Hcl	27	12
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Spironolactone	Spironolactone	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Labetalol Hcl	Labetalol Hcl	24	suppressed
Atenolol	Atenolol	23	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Divalproex Sodium Er	Divalproex Sodium	23	suppressed
Hydrocortisone	Hydrocortisone	23	suppressed
Lactulose	Lactulose	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Oxcarbazepine	Oxcarbazepine	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Ciclopirox	Ciclopirox	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Varenicline Tartrate	Varenicline Tartrate	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	17
Cefdinir	Cefdinir	17	14
Finasteride	Finasteride	17	suppressed
Linzess	Linaclotide	17	suppressed
Naproxen	Naproxen	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Clonidine	Clonidine	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Colchicine	Colchicine	13	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Torsemide	Torsemide	12	suppressed
Valsartan	Valsartan	12	suppressed
Easy Comfort Pen Needles	Pen Needle, Diabetic	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error